Bridget E. Bunner

Array ( [id] => 10142260 [patent_doc_number] => 09175059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Anticancer fusion protein comprising trail and a growth factor receptor inhibitor' [patent_app_type] => utility [patent_app_number] => 13/978090 [patent_app_country] => US [patent_app_date] => 2012-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 26554 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568660 [patent_doc_number] => 20140186373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'ANTIBODY FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/991984 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11818 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055981 [patent_doc_number] => 20120077733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTAGONISTS AGAINST INTERACTION OF PF4 AND RANTES' [patent_app_type] => utility [patent_app_number] => 13/315088 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077733.pdf [firstpage_image] =>[orig_patent_app_number] => 13315088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10128170 [patent_doc_number] => 09161991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Anticancer fusion protein comprising TRAIL and interferon' [patent_app_type] => utility [patent_app_number] => 13/989969 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 18770 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509150 [patent_doc_number] => 20120308558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'Methods of Using Antibodies That Bind The Glutamate Ligand Binding Region of Notch1' [patent_app_type] => utility [patent_app_number] => 13/308224 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31212 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13308224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015523 [patent_doc_number] => 20130230487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'Immunomodulatory Methods and Systems for Treatment and/or Prevention of Hypertension' [patent_app_type] => utility [patent_app_number] => 13/884911 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20678 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9147839 [patent_doc_number] => 20130302362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Immunomodulatory Compositions, Methods and Systems Comprising Immunogenic Fragments of ApoB-100' [patent_app_type] => utility [patent_app_number] => 13/884916 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19556 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094023 [patent_doc_number] => 20120082622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Macaca fascicularis CCL17' [patent_app_type] => utility [patent_app_number] => 13/245349 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5376 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082622.pdf [firstpage_image] =>[orig_patent_app_number] => 13245349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754463 [patent_doc_number] => 20120027685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'DETERMINING THE CAPABILITY OF A TEST COMPOUND TO AFFECT SOLID TUMOR STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/241701 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 46776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027685.pdf [firstpage_image] =>[orig_patent_app_number] => 13241701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817475 [patent_doc_number] => 20120064095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'TOLL-LIKE RECEPTOR 3 ANTAGONISTS FOR THE TREATMENT OF METABOLIC AND CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 13/230060 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 35744 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064095.pdf [firstpage_image] =>[orig_patent_app_number] => 13230060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527389 [patent_doc_number] => 08303958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Method of treating immunological disorders by administering truncated BAFF receptors' [patent_app_type] => utility [patent_app_number] => 13/213826 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 11615 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733321 [patent_doc_number] => 20120015889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY' [patent_app_type] => utility [patent_app_number] => 13/209806 [patent_app_country] => US [patent_app_date] => 2011-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5570 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015889.pdf [firstpage_image] =>[orig_patent_app_number] => 13209806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335123 [patent_doc_number] => 20120201826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Anti-RANTES Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/207774 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30572 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13207774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742325 [patent_doc_number] => 20120020990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 13/190247 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30987 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020990.pdf [firstpage_image] =>[orig_patent_app_number] => 13190247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7755602 [patent_doc_number] => 20120028281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY' [patent_app_type] => utility [patent_app_number] => 13/186657 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31329 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028281.pdf [firstpage_image] =>[orig_patent_app_number] => 13186657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8338046 [patent_doc_number] => RE043581 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-08-14 [patent_title] => 'Peptide epitopes of apolipoprotein B' [patent_app_type] => reissue [patent_app_number] => 13/177897 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11506 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982273 [patent_doc_number] => 08513388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Anti-Notch3 antibodies' [patent_app_type] => utility [patent_app_number] => 13/174285 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 16306 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891071 [patent_doc_number] => 20130164254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'ANTICANCER FUSION PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/806072 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34749 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7485820 [patent_doc_number] => 20110250625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'GAMMA SECRETASE NOTCH BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/166103 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9013 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250625.pdf [firstpage_image] =>[orig_patent_app_number] => 13166103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567956 [patent_doc_number] => 20110288019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'METHODS OF INCREASING PLATELET AND HEMATOPOIETIC STEM CELL PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/164707 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8297 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288019.pdf [firstpage_image] =>[orig_patent_app_number] => 13164707 [rel_patent_id] =>[rel_patent_doc_number] =>)